Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        331-340 of 1462 results for 'vaccine'

        Refine search

        Research

        Risk of adverse maternal and foetal outcomes associated with inactivated influenza vaccination in first trimester of pregnancy

        In many countries, influenza vaccination is routinely recommended during any stage of pregnancy, yet uptake remains low, particularly in the first trimester. This is thought to be due to maternal concerns regarding vaccine safety. We evaluated the safety of influenza vaccination in the first trimester of pregnancy. ...

        Research

        Maternal, umbilical cord and neonatal inflammatory and hematologic markers in histologic chorioamnionitis

        Maternal, umbilical cord, neonatal inflammatory, hematologic markers, histologic chorioamnionitis... ...

        AusVaxSafety (previously FAST)

        Why are we doing AusVaxSafety? Like any other medication, vaccines can have side effects which are usually mild and short-lasting and do not need ...

        Pertussis (Whooping Cough)

        Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@telethonkids.org.au Pertussis, also ...

        News & Events

        Meningitis study aims for fewer needles

        Perth researchers are investigating a new combined vaccine to protect against three causes of potentially deadly bacterial meningitis. ...

        People

        Associate Professor Lea-Ann Kirkham

        Co-Head, Bacterial Respiratory Infectious Disease Group; Microbiology Lead, Wesfarmers Centre of Vaccines & Infectious Diseases ...

        Research

        Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021

        Within the first 4 months of the Western Australian COVID-19 immunisation programme, 49 suspected anaphylaxis cases were reported to the vaccine safety surveillance system. Twelve reports met Brighton Collaboration case definition, corresponding to rates of 15.9 and 17.7 per million doses of Vaxzevria and Comirnaty administered respectively. ...

        Pneumococcal Disease

        Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@telethonkids.org.au Pneumococcal ...

        Research

        A Phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK's meningococcal Group B and combined ABCWY vaccines when administered to healthy adolescents and young adults (Quintet)

        Jennifer Peter Kent Richmond J PC RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@telethonkids.org.au ...

        Research

        A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 in healthy infants (PNEU-PED-EU-1)

        Jennifer Peter Kent Richmond J PC RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@telethonkids.org.au ...

        Page 34 of 147